Patents by Inventor Antonia Kathryn Roseweir

Antonia Kathryn Roseweir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND, USE AND METHOD
    Publication number: 20150057430
    Abstract: The present invention relates to the use of an antagonist of kisspeptin in the manufacture of a medicament for the treatment of a condition induced and/or worsened by kisspeptin activity in an individual. The invention also provides certain defined peptide molecules, which may act as an antagonist of kisspeptin, which are of use in treating a condition induced and/or worsened by kisspeptin activity in an individual. In addition, the invention provides methods of identifying and/or using antagonists of kisspeptin and/or the defined peptides, and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 26, 2014
    Publication date: February 26, 2015
    Inventors: Robert Peter Millar, Antonia Kathryn Roseweir
  • Compound, use and method
    Patent number: 8916681
    Abstract: The present invention relates to the use of an antagonist of kisspeptin in the manufacture of a medicament for the treatment of a condition induced and/or worsened by kisspeptin activity in an individual. The invention also provides certain defined peptide molecules, which may act as an antagonist of kisspeptin, which are of use in treating a condition induced and/or worsened by kisspeptin activity in an individual. In addition, the invention provides methods of identifying and/or using antagonists of kisspeptin and/or the defined peptides, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: October 8, 2008
    Date of Patent: December 23, 2014
    Assignee: Medical Research Council
    Inventors: Robert Peter Millar, Antonia Kathryn Roseweir
  • Compound, Use and Method
    Publication number: 20110046068
    Abstract: The present invention relates to the use of an antagonist of kisspeptin in the manufacture of a medicament for the treatment of a condition induced and/or worsened by kisspeptin activity in an individual. The invention also provides certain defined peptide molecules, which may act as an antagonist of kisspeptin, which are of use in treating a condition induced and/or worsened by kisspeptin activity in an individual. In addition, the invention provides methods of identifying and/or using antagonists of kisspeptin and/or the defined peptides, and pharmaceutical compositions thereof.
    Type: Application
    Filed: October 8, 2008
    Publication date: February 24, 2011
    Inventors: Robert Peter Millar, Antonia Kathryn Roseweir